Description
Uperio FCT is a prescription medication that combines two active ingredients: Sacubitril and Valsartan. It is used primarily in the management of heart failure with reduced ejection fraction and is designed to improve cardiovascular outcomes. Sacubitril is a neprilysin inhibitor that helps increase levels of beneficial peptides, contributing to vasodilation and reducing heart strain, while Valsartan is an angiotensin II receptor blocker (ARB) that helps relax blood vessels and lower blood pressure.
Dosage/Direction: The typical starting dose for adults is one 200 mg tablet taken twice daily, but a healthcare provider may adjust the dosage based on the patient’s condition and response to treatment. It is important to follow the healthcare provider’s specific dosing instructions, and the medication should be taken consistently, either with or without food.
Side Effects: Common side effects can include hypotension (low blood pressure), hyperkalemia (increased potassium levels), cough, dizziness, and fatigue. It’s important for patients to monitor for symptoms of allergic reactions, changes in kidney function, or other serious effects, and to report these to their healthcare provider.
